Clinical Trial Update: A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing two experimental malaria vaccines, RH5.2-VLP and R21, for Falciparum malaria; the study is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• R21
• RH5.2-VLP

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Plasmodium Falciparum | Phase 1 | Status: ACTIVE_NOT_RECRUITING